A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia

Prebet, T., Goldberg, A. D., Jurcic, J. G., Khaled, S., Dail, M., Feng, Y., Green, C., Li, C., Ma, C., Medeiros, B. C., Yan, M., & Grunwald, M. R. (2022). A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia. Leukemia & Lymphoma, 63(9), 2180–2188. https://doi.org/10.1080/10428194.2022.2057484
Authors:
Thomas Prebet
Aaron D Goldberg
Joseph G Jurcic
Samer Khaled
Monique Dail
Yuning Feng
Cherie Green
Chunze Li
Connie Ma
Bruno C Medeiros
Mark Yan
Michael R Grunwald
Affiliated Authors:
Joseph G Jurcic
Columbia Affiliation:
Subjects:
Azacitidine (MeSH)
Leukemia, Myeloid, Acute (MeSH)
Author Keywords:
oncology
checkpoint inhibitor
pd-l1 inhibitor
elink
Publication Type:
Article
Unique ID:
10.1080/10428194.2022.2057484
PMID:
35491816
DOI:
10.1080/10428194.2022.2057484
Journal:
Leukemia and Lymphoma
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record

Record Created: